| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| AKRO | Akero Therapeutics, Inc. | Chief Scientific Officer | $6.97M | -$9.31M | -57.2% | Nov 17, 2025 |
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|